18th February 2025
This report evaluates the economic impacts of legalising and regulating cannabis for adult non-medical use in the UK from a Treasury perspective of income and spending. The report focuses on government revenues (corporation and income tax, VAT, National Insurance, licensing fees, and, in the scenario of a state monopoly model, profits), savings across the criminal justice system (CJS) from reduced costs on enforcement, and the costs of administering a regulatory model.
For Transform, economic arguments for cannabis, though significant, are secondary to public health and social justice policy priorities. But the economic dimensions of the cannabis reform debate are undoubtedly gaining
political salience, particularly as governments face growing budgetary pressures. Public support for cannabis reform, particularly for economic reasons, such as disrupting illegal profits and the potential tax income, is growing in both the U.S. and the UK.
This report analyses three different regulatory scenarios:
1. Home-grow provision for personal use, and non-profit membership-based associations, with no commercial retail
2. Hybrid model including home grow, non-profit associations and regulated commercial retail
3. A Hybrid model Home grow, non-profit associations, and commercial retail operating under a state monopoly (profits on retail sale accrue to the state)
The production of this report was only made possible by the generous supporters of our Legalise UK Cannabis campaign - thank you!
If you agree it's high time for the UK to finally make the sensible decision to legally regulate cannabis, help us make this happen. Donate to our crowdfunder and support us today!
You can also donate using PayPal, complete your payment in just a few clicks via the button below. PayPal securely processes donations for Transform Drug Policy Foundation.